Systemic and local cytokine profile and risk factors for persistent allergic airway inflammation in patients sensitised to house dust mite allergens

Table 5 Risk for development of allergic airway diseases

	B	Sig	Exp (B)	95% Confidence Interval for Exp(B)
	B	Sig	Exp (B)	Lower bound	Upper bound
Risk for development of AR for healthy individuals
Serum IFN-gamma	− 0.71	0.02	0.49	0.274	0.874
Age	− 0.08	0.04	0.92	0.851	0.996
Risk for development of AA for patients with AR
Serum IL-22	0.14	0.02	1.15	1.024	1.299
Serum IL-10	− 0.27	0.01	0.07	0.009	0.504
IL-10 in nasal lavage	2.30	0.03	9.98	1.198	83.138
IL-33 in nasal lavage	0.57	0.05	1.77	1.011	3.091
Vitamin D	− 0.09	0.03	0.91	0.842	0.990

ISSN: 1471-2466